Staying on top of drug safety.

Drug safety and pharmacovigilance professionals are increasingly challenged, having to do more with less. The key to your success is implementing automation, adopting advanced technologies, and leveraging insights from analytics that improve compliance and product safety. Curexbio provides flexible, innovative, scalable solutions to meet your unique business requirements.

Pharmacovigilance

CurexBio's Inclusive Pharmacovigilance Services

CurexBio offers a full suite of highly flexible, innovative, and scalable pharmacovigilance services, designed to meet your unique needs from early development to post-marketing surveillance. Our technology-driven approach and experienced team ensure accurate and efficient management of adverse event data, minimizing risk and upholding regulatory compliance.

Adverse Event (AE) / Serious Adverse Event (SAE) Management

Our core pharmacovigilance service includes comprehensive Adverse Event (AE) and Serious Adverse Event (SAE) management. This involves:

  • 24/7 Case Intake: Establishing mechanisms for prompt receipt of safety information from all sources globally.
  • Case Triage and Data Entry: Efficiently triaging incoming cases and accurately entering data into validated safety databases.
  • Medical Coding: Standardized coding of medical events and drug information using MedDRA and WHO Drug dictionaries.
  • Quality Control & Reconciliation: Rigorous quality control checks and reconciliation with clinical trial databases to ensure data consistency and accuracy.
Expedited & Aggregate Reporting

Timely and accurate reporting is paramount. We specialize in the preparation and submission of all necessary expedited and aggregate safety reports, including:

  • SUSARs: Expedited reporting of Suspected Unexpected Serious Adverse Reactions to regulatory authorities and ethics committees worldwide.
  • DSURs (Development Safety Update Reports): Annual reports for investigational products in clinical development.
  • PSURs (Periodic Safety Update Reports) / PBRERs (Periodic Benefit-Risk Evaluation Reports): Regular post-marketing reports summarizing the worldwide safety experience of a marketed product, including its benefit-risk profile.
Signal Detection & Risk Management

Our proactive approach to drug safety includes advanced signal detection and risk management. We continuously monitor safety data to identify new or changing safety signals, evaluate their significance, and assess their impact on the product’s benefit-risk profile. This includes:

  • Signal Validation: Confirming potential signals through further analysis.
  • Risk Management Plans (RMPs): Drafting, reviewing, and implementing comprehensive RMPs to identify, characterize, and minimize risks.
  • Risk Evaluation and Mitigation Strategies (REMS): Where required, developing and managing REMS programs to ensure safe use of certain drugs.
Medical Review and Causality Assessment

Our safety physicians offer expert medical review and causality assessment for individual case safety reports, evaluating the relationship between adverse events and investigational products, crucial for regulatory reporting and benefit-risk assessment.

Safety Database Management

We leverage advanced safety databases like Argus and ArisG for secure, efficient management, ensuring data integrity and compliance with 21 CFR Part 11 and ICH E2B standards. Our expertise also includes setting up and maintaining PV systems to meet regulatory and operational requirements.

Audits, Inspections Readiness & PV System Support

CurexBio guarantees consistent compliance with Good Pharmacovigilance Practices (GVP) by promoting PV audits, internal audits, inspection readiness, mock inspections, vendor/affiliate audits, training, and on-going support for PV systems, encompassing SOP writing, targeted training, and regulatory updates.

Pharmacovigilance for Clinical Trials

Pharmacovigilance for Post-market Studies

Comprehensive Pharmacovigilance

Setting up and managing PV systems to support comprehensive safety monitoring

Maintaining PV systems to ensure they meet regulatory and operational requirements

Supporting system audits to validate data integrity and compliance

Ensuring data security and safe transfer of sensitive information

Providing regulatory support for all safety reporting needs

Support Services Outsourcing

Support Services Outsourcing

PV Audits and Training

Conducting internal audits to assess pharmacovigilance practices

Providing training and mock inspections to prepare teams for regulatory audits

Supporting audit and inspection readiness across the organization

Managing vendor and affiliate audits to ensure third-party compliance

Request For Proposal

We offer an array of niche and full-fledged CRO services, from clinical trial protocol development to post-marketing surveillance. Streamline Your Drug Development with Curexbio CRO Expertise

Curexbio Insights Hub

Dive into the latest research, insights, and innovations with our team of experts in the fields that matter most to clinical advancement.
Curexbio Insights Hub